1. Home
  2. SGHT vs GHG Comparison

SGHT vs GHG Comparison

Compare SGHT & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

N/A

Current Price

$8.16

Market Cap

309.6M

Sector

Health Care

ML Signal

N/A

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.05

Market Cap

116.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
GHG
Founded
2011
2004
Country
United States
China
Employees
N/A
N/A
Industry
Medical Specialities
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
309.6M
116.0M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
SGHT
GHG
Price
$8.16
$1.05
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$9.08
N/A
AVG Volume (30 Days)
206.2K
8.3K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
4.15%
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
N/A
Revenue This Year
$11.67
$19.02
Revenue Next Year
$10.39
$8.26
P/E Ratio
N/A
$5.76
Revenue Growth
N/A
N/A
52 Week Low
$3.19
$1.01
52 Week High
$9.24
$2.36

Technical Indicators

Market Signals
Indicator
SGHT
GHG
Relative Strength Index (RSI) 56.69 31.58
Support Level $8.00 N/A
Resistance Level $8.80 $1.15
Average True Range (ATR) 0.35 0.04
MACD -0.15 -0.00
Stochastic Oscillator 29.36 26.47

Price Performance

Historical Comparison
SGHT
GHG

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

Share on Social Networks: